Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells

BackgroundCaspase-8 is a key upstream mediator in death receptor-mediated apoptosis and also participates in mitochondria-mediated apoptosis via cleavage of proapoptotic Bid. However, the role of caspase-8 in p53- and p73-dependent apoptosis induced by genotoxic drugs remains unclear. We recently reported that the reconstitution of procaspase-8 is sufficient for sensitizing cisplatin- but not etoposide-induced apoptosis, in chemoresistant and caspase-8 deficient HOC313 head and neck squamous cell carcinoma (HNSCC) cells.ResultsWe show that p53/p73-dependent caspase-8 activation is required for sensitizing etoposide-induced apoptosis by utilizing HOC313 cells carrying a temperature-sensitive p53G285K mutant. Restoration of wild-type p53 function under the permissive conditions, together with etoposide treatment, led to substantial transcriptional activation of proapoptotic Noxa and PUMA, but failed to induce apoptosis. In addition to p53 restoration, caspase-8 reconstitution was needed for sensitization to etoposide-induced apoptosis, mitochondria depolarization, and cleavage of the procaspases-3, and -9. In etoposide-sensitive Ca9-22 cells carrying a temperature-insensitive mutant p53, siRNA-based p73 knockdown blocked etoposide-induced apoptosis and procaspase-8 cleavage. However, induction of p73 protein and up-regulation of Noxa and PUMA, although observed in Ca9-22 cells, were hardly detected in etoposide-treated HOC313 cells under non-permissive conditions, suggesting a contribution of p73 reduction to etoposide resistance in HOC313 cells. Finally, the caspase-9 inhibitor Ac-LEHD-CHO or caspase-9 siRNA blocked etoposide-induced caspase-8 activation, Bid cleavage, and apoptosis in both cell lines, indicating that p53/p73-dependent caspase-8 activation lies downstream of mitochondria.Conclusionswe conclude that p53 and p73 can act as upstream regulators of caspase-8, and that caspase-8 is an essential mediator of the p53/p73-dependent apoptosis induced by etoposide in HNSCC cells. Our data suggest the importance of caspase-8-mediated positive feedback amplification in the p53/p73-dependent apoptosis induced by etoposide in HNSCC cells.

[1]  R. K Srivastava,et al.  Inhibition of drug‐induced Fas ligand transcription and apoptosis by Bcl‐XL , 2001, Molecular and Cellular Biochemistry.

[2]  I. H. Engels,et al.  Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. , 1999, Blood.

[3]  C. Thompson,et al.  The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability , 2000, Cell Death and Differentiation.

[4]  S. Tait,et al.  TRAIL Receptor and CD95 Signal to Mitochondria via FADD, Caspase-8/10, Bid, and Bax but Differentially Regulate Events Downstream from Truncated Bid* , 2002, The Journal of Biological Chemistry.

[5]  I. Jeremias,et al.  Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells , 2008, Oncogene.

[6]  Emad S. Alnemri,et al.  Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner , 1999, The Journal of cell biology.

[7]  J. Falkenburg,et al.  Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria , 2006, Apoptosis.

[8]  W. Hahn,et al.  Chemosensitivity linked to p73 function. , 2003, Cancer cell.

[9]  Yusuke Nakamura,et al.  p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.

[10]  M. Manns,et al.  The Human Caspase-8 Promoter Sustains Basal Activity through SP1 and ETS-like Transcription Factors and Can Be Up-regulated by a p53-dependent Mechanism* , 2003, Journal of Biological Chemistry.

[11]  Shengliang Zhang,et al.  Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines. , 2006, Journal of medical and dental sciences.

[12]  S. Fulda,et al.  Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer , 2001, Oncogene.

[13]  Y. Hirano,et al.  A temperature sensitive mutant of the human p53, Val138, arrests rat cell growth without induced expression of cip1/waf1/sdi1 after temperature shift-down. , 1995, Oncogene.

[14]  R. Liang,et al.  Hypermethylation of gene promoters in hematological neoplasia , 2002, Hematological oncology.

[15]  T. Kuwana,et al.  Apoptosis Induction by Caspase-8 Is Amplified through the Mitochondrial Release of Cytochrome c * , 1998, The Journal of Biological Chemistry.

[16]  M. Ikeda,et al.  Association of caspase-8 mutation with chemoresistance to cisplatin in HOC313 head and neck squamous cell carcinoma cells. , 2009, Biochemical and biophysical research communications.

[17]  K. Schulze-Osthoff,et al.  Caspase-8 Can Be Activated by Interchain Proteolysis without Receptor-triggered Dimerization during Drug-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[18]  A. Matsuda,et al.  2-Chloro-2′-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4 , 2000, Leukemia.

[19]  G. Kroemer,et al.  Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis , 2001, Oncogene.

[20]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[21]  G. Salvesen,et al.  Mechanisms of caspase activation. , 2003, Current opinion in cell biology.

[22]  B. Dörken,et al.  Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop , 2003, Oncogene.

[23]  V. Kidd,et al.  Caspase-8 Activation and Bid Cleavage Contribute to MCF7 Cellular Execution in a Caspase-3-dependent Manner during Staurosporine-mediated Apoptosis* , 2000, The Journal of Biological Chemistry.

[24]  G. Melino,et al.  One, two, three--p53, p63, p73 and chemosensitivity. , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[25]  J. Houghton,et al.  Thymineless death in colon carcinoma cells is mediated via fas signaling. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Oren,et al.  Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.

[27]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[28]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[29]  K. Bhalla,et al.  The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. , 2000, Cancer research.

[30]  R. Iggo,et al.  Mammalian p53 can function as a transcription factor in yeast. , 1992, Nucleic acids research.

[31]  M. Peter,et al.  FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* , 1997, The Journal of Biological Chemistry.

[32]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[33]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[34]  D. Green,et al.  p73 Induces Apoptosis via PUMA Transactivation and Bax Mitochondrial Translocation* , 2004, Journal of Biological Chemistry.

[35]  D. Green,et al.  Caspases Induce Cytochrome c Release from Mitochondria by Activating Cytosolic Factors* , 1999, The Journal of Biological Chemistry.

[36]  J. Pan,et al.  Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel. , 2001, The Journal of clinical endocrinology and metabolism.

[37]  N. Tsuchida,et al.  Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. , 1992, Oncogene.

[38]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[39]  N. Nonomura,et al.  Loss of p73 induction in a cisplatin-resistant bladder cancer cell line. , 2001, Molecular urology.

[40]  M MacFarlane,et al.  Distinct Caspase Cascades Are Initiated in Receptor-mediated and Chemical-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[41]  L. Ellisen,et al.  p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. , 2006, Cancer cell.

[42]  Antonio Costanzo,et al.  Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells , 2008, Molecular Cancer Therapeutics.

[43]  S. Korsmeyer,et al.  Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.

[44]  R. Veale,et al.  Role of p53/FAK association and p53Ser46 phosphorylation in staurosporine‐mediated apoptosis: Wild type versus mutant p53‐R175H , 2009, FEBS letters.

[45]  Jeong Woo Park,et al.  NF‐κB activation is required for cisplatin‐induced apoptosis in head and neck squamous carcinoma cells , 2006 .

[46]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[47]  J. Gueulette,et al.  Caspase 8-mediated cleavage of the pro-apoptotic BCL-2 family member BID in p53-dependent apoptosis. , 2003, Biochemical and biophysical research communications.

[48]  W. V. van Blitterswijk,et al.  Common Regulation of Apoptosis Signaling Induced by CD95 and the DNA-damaging Stimuli Etoposide and γ-Radiation Downstream from Caspase-8 Activation* , 1999, The Journal of Biological Chemistry.

[49]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[50]  G. Peters,et al.  Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  B. Dörken,et al.  Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells , 2001 .

[52]  S. Fulda,et al.  Cytotoxic drugs and the CD95 pathway , 1999, Leukemia.

[53]  B. Gusterson,et al.  p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. , 2003, Cancer cell.

[54]  U. Moll,et al.  The mitochondrial p53 pathway. , 2009, Biochimica et biophysica acta.

[55]  A. Oniscu,et al.  p73α is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes , 2004, Journal of Clinical Pathology.